# Electra Therapeutics, Inc. — Form D

Electra Therapeutics, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-30. The offering totals $184.1M, of which $134.2M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-10-30
- Form: D
- Accession: 0001231919-25-000372
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $184.1M
- Amount sold: $134.2M
- Remaining: $49.9M
- Investors: 19
- Date of first sale: 2025-10-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-562489

## Issuer

- Name: Electra Therapeutics, Inc.
- CIK: 0002088082
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 230 EAST GRAND AVENUE, SUITE S-100, SOUTH SAN FRANCISCO, CA, 94080
- Phone: (888) 743-2290

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Quehuong (Kathy) Dong, Pharm.D. | Director | SOUTH SAN FRANCISCO, CA |
| Matthew Fust | Director | SOUTH SAN FRANCISCO, CA |
| Thomas Geninatti, Ph.D. | Director | SOUTH SAN FRANCISCO, CA |
| Carl Gordon, Ph.D. | Director | SOUTH SAN FRANCISCO, CA |
| Beth Seidenberg, M.D. | Director | SOUTH SAN FRANCISCO, CA |
| Nancy Stagliano, Ph.D. | Director | SOUTH SAN FRANCISCO, CA |
| Quehuong (Kathy) Dong, Pharm.D. | Executive Officer | SOUTH SAN FRANCISCO, CA |

## More

- [CIK 2088082 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2088082&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001231919-25-000372.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.